BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2565 related articles for article (PubMed ID: 7606887)

  • 1. Antitumor effects of liposomal IL1 alpha and TNF alpha against the pulmonary metastases of the B16F10 murine melanoma in syngeneic mice.
    Saito M; Fan D; Lachman LB
    Clin Exp Metastasis; 1995 Jul; 13(4):249-59. PubMed ID: 7606887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors.
    Nakamura S; Nakata K; Kashimoto S; Yoshida H; Yamada M
    Jpn J Cancer Res; 1986 Aug; 77(8):767-73. PubMed ID: 3093425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic potential of liposomes containing tumor necrosis factor-alpha against sensitive and resistant target cells.
    Nii A; Fan D; Fidler IJ
    J Immunother (1991); 1991 Feb; 10(1):13-9. PubMed ID: 2012796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-alpha show improved pharmacokinetics and biological activity and reduced toxicity in mice.
    Kedar E; Palgi O; Golod G; Babai I; Barenholz Y
    J Immunother; 1997 May; 20(3):180-93. PubMed ID: 9181456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects in vitro and in vivo and mechanisms of protection against melanoma B16F10-Nex2 cells by fastuosain, a cysteine proteinase from Bromelia fastuosa.
    Guimarães-Ferreira CA; Rodrigues EG; Mortara RA; Cabral H; Serrano FA; Ribeiro-dos-Santos R; Travassos LR
    Neoplasia; 2007 Sep; 9(9):723-33. PubMed ID: 17898868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways.
    Zhang L; Tao L; Shi T; Zhang F; Sheng X; Cao Y; Zheng S; Wang A; Qian W; Jiang L; Lu Y
    IUBMB Life; 2015 Oct; 67(10):778-88. PubMed ID: 26452780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4.
    Kolber DL; Knisely TL; Maione TE
    J Natl Cancer Inst; 1995 Feb; 87(4):304-9. PubMed ID: 7707422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumors.
    Noguchi K; Inagawa H; Tsuji Y; Morikawa A; Mizuno D; Soma G
    J Immunother (1991); 1991 Apr; 10(2):105-11. PubMed ID: 2043590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A YIGSR-containing novel mutein without the detrimental effect of human TNF-alpha of enhancing experimental pulmonary metastasis.
    Miyata K; Kato M; Shikama H; Nishimura K; Sakae N; Kawagoe K; Nishikawa T; Kuroda K; Yamaguchi K; Aoyama Y
    Clin Exp Metastasis; 1992 Jul; 10(4):267-72. PubMed ID: 1617834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo effect of IFNalpha on B16F10 melanoma in two models: subcutaneous (C57BL6J mice) and lung metastasis (Swiss mice).
    Martínez Conesa C; Alvarez Sánchez N; Vicente Ortega V; García Reverte J; Pascual Carpe F; Campos Aranda M
    Biomed Pharmacother; 2009 May; 63(4):305-12. PubMed ID: 19171452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of glycyrrhizin on experimental pulmonary metastasis in mice inoculated with B16 melanoma.
    Kobayashi M; Fujita K; Katakura T; Utsunomiya T; Pollard RB; Suzuki F
    Anticancer Res; 2002; 22(6C):4053-8. PubMed ID: 12553032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.
    Young MR; Wright MA
    Cancer Res; 1992 Nov; 52(22):6335-40. PubMed ID: 1423279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
    Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
    Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of liposomal rhinacanthin-N isolated from Rhinacanthus nasutus on pulmonary metastasis in mice.
    Siripong P; Yahuafai J; Piyaviriyakul S; Kanokmedhakul K; Koide H; Ishii T; Shimizu K; Ruchirawat S; Oku N
    Biol Pharm Bull; 2012; 35(7):1197-200. PubMed ID: 22791173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus.
    Ju DW; Cao X; Acres B
    J Cancer Res Clin Oncol; 1996; 122(12):716-22. PubMed ID: 8954168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease.
    Wang XY; Kazim L; Repasky EA; Subjeck JR
    Int J Cancer; 2003 Jun; 105(2):226-31. PubMed ID: 12673684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
    J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
    Zou Y; Ling YH; Van NT; Priebe W; Perez-Soler R
    Cancer Res; 1994 Mar; 54(6):1479-84. PubMed ID: 8137251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
    Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
    J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 129.